Glucocorticoid Receptor Signaling in the Eye

Overview

Journal Steroids

Publisher Elsevier

Specialty Biochemistry

Date 2017 Nov 14

PMID 29129720

Citations 32

Authors

Rania S Sulaiman

Mahita Kadmiel

John A Cidlowski

Affiliations

Soon will be listed here.

Abstract

Glucocorticoids (GCs) are essential steroid hormones that regulate numerous metabolic and homeostatic functions in almost all physiological systems. Synthetic glucocorticoids are among the most commonly prescribed drugs for the treatment of various conditions including autoimmune, allergic and inflammatory diseases. Glucocorticoids are mainly used for their potent anti-inflammatory and immunosuppressive activities mediated through signal transduction by their nuclear receptor, the glucocorticoid receptor (GR). Emerging evidence showing that diverse physiological and therapeutic actions of glucocorticoids are tissue-, cell-, and sex-specific, suggests more complex actions of glucocorticoids than previously anticipated. While several synthetic glucocorticoids are widely used in the ophthalmology clinic for the treatment of several ocular diseases, little is yet known about the mechanism of glucocorticoid signaling in different layers of the eye. GR has been shown to be expressed in different cell types of the eye such as cornea, lens, and retina, suggesting an important role of GR signaling in the physiology of these ocular tissues. In this review, we provide an update on the recent findings from in vitro and in vivo studies reported in the last 5 years that aim at understanding the role of GR signaling specifically in the eye. Advances in studying the physiological effects of glucocorticoids in the eye are vital for the elaboration of optimized and targeted GC therapies with potent anti-inflammatory potential while minimizing adverse effects.

Citing Articles

Glucocorticoid-Dependent Retinal Degeneration and Vision Impairment in Mice Susceptible to Prenatal Stress-Induced Behavioral Abnormalities.

Ryu M, Jung J, Suh H, Lee C, Kim M, Oh J Cell Mol Neurobiol. 2024; 45(1):7.

PMID: 39714626 PMC: 11666777. DOI: 10.1007/s10571-024-01525-x.

Regulating the formation of Müller glia-derived progenitor cells in the retina.

Taylor O, El-Hodiri H, Palazzo I, Todd L, Fischer A Glia. 2024; 73(1):4-24.

PMID: 39448874 PMC: 11660542. DOI: 10.1002/glia.24635.

Glucocorticoid Receptor Signaling Is Critical for Mouse Corneal Development, Inhibition of Inflammatory Response, and Neovascularization of the Cornea.

Kadmiel M, Diaz-Jimenez D, Oakley R, Petrillo M, He B, Xu X Am J Pathol. 2024; 194(10):1938-1950.

PMID: 39322334 PMC: 11423760. DOI: 10.1016/j.ajpath.2024.06.005.

A bibliometric and visualized analysis of the pathogenesis of cataracts from 1999 to 2023.

Shu X, Liu Y, He F, Gong Y, Li J Heliyon. 2024; 10(4):e26044.

PMID: 38390089 PMC: 10881887. DOI: 10.1016/j.heliyon.2024.e26044.

The glucocorticoid receptor as a master regulator of the Müller cell response to diabetic conditions in mice.

Pfaller A, Kaplan L, Carido M, Grassmann F, Diaz-Lezama N, Ghaseminejad F J Neuroinflammation. 2024; 21(1):33.

PMID: 38273366 PMC: 10809506. DOI: 10.1186/s12974-024-03021-x.

References

Gabelt B, Kaufman P . Changes in aqueous humor dynamics with age and glaucoma. Prog Retin Eye Res. 2005; 24(5):612-37. DOI: 10.1016/j.preteyeres.2004.10.003. View

Kadmiel M, Janoshazi A, Xu X, Cidlowski J . Glucocorticoid action in human corneal epithelial cells establishes roles for corticosteroids in wound healing and barrier function of the eye. Exp Eye Res. 2016; 152:10-33. PMC: 5097880. DOI: 10.1016/j.exer.2016.08.020. View

Wang C, Dawes L, Liu Y, Wen L, Lovicu F, McAvoy J . Dexamethasone influences FGF-induced responses in lens epithelial explants and promotes the posterior capsule coverage that is a feature of glucocorticoid-induced cataract. Exp Eye Res. 2013; 111:79-87. PMC: 3664133. DOI: 10.1016/j.exer.2013.03.006. View

Zhang X, Lai D, Bao S, Hambly B, Gillies M . Triamcinolone acetonide inhibits p38MAPK activation and neuronal apoptosis in early diabetic retinopathy. Curr Mol Med. 2013; 13(6):946-58. DOI: 10.2174/1566524011313060007. View

Arimura S, Takamura Y, Miyake S, Gozawa M, Iwasaki K, Tomomatsu T . The effect of triamcinolone acetonide or bevacizumab on the levels of proinflammatory cytokines after retinal laser photocoagulation in pigmented rabbits. Exp Eye Res. 2016; 149:1-7. DOI: 10.1016/j.exer.2016.06.004. View

Dismuke W, Klingeborn M, Stamer W . Mechanism of Fibronectin Binding to Human Trabecular Meshwork Exosomes and Its Modulation by Dexamethasone. PLoS One. 2016; 11(10):e0165326. PMC: 5081181. DOI: 10.1371/journal.pone.0165326. View

Raffaele N, Marchese A, Ghigo D . Compared antioxidant activity among corticosteroids on cultured retinal pigment epithelial cells. Graefes Arch Clin Exp Ophthalmol. 2016; 254(12):2411-2416. DOI: 10.1007/s00417-016-3519-3. View

Kelly A, Bowen H, Jee Y, Mahfiche N, Soh C, Lee T . The glucocorticoid receptor beta isoform can mediate transcriptional repression by recruiting histone deacetylases. J Allergy Clin Immunol. 2007; 121(1):203-208.e1. DOI: 10.1016/j.jaci.2007.09.010. View

Augustin A, Schmidt-Erfurth U . Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration. Ophthalmology. 2005; 113(1):14-22. DOI: 10.1016/j.ophtha.2005.09.002. View

10.

Stahn C, Buttgereit F . Genomic and nongenomic effects of glucocorticoids. Nat Clin Pract Rheumatol. 2008; 4(10):525-33. DOI: 10.1038/ncprheum0898. View

11.

Bermudez J, Webber H, Brown B, Braun T, Clark A, Mao W . A Comparison of Gene Expression Profiles between Glucocorticoid Responder and Non-Responder Bovine Trabecular Meshwork Cells Using RNA Sequencing. PLoS One. 2017; 12(1):e0169671. PMC: 5222504. DOI: 10.1371/journal.pone.0169671. View

12.

Gu R, Lei B, Shu Q, Li G, Xu G . Glucocorticoid-induced leucine zipper overexpression inhibits lipopolysaccharide-induced retinal inflammation in rats. Exp Eye Res. 2017; 165:151-163. DOI: 10.1016/j.exer.2017.02.011. View

13.

Miyamoto N, Iossifov D, Metge F, Behar-Cohen F . Early effects of intravitreal triamcinolone on macular edema: mechanistic implication. Ophthalmology. 2006; 113(11):2048-53. DOI: 10.1016/j.ophtha.2006.05.037. View

14.

Clark R, Nosie A, Walker T, Faralli J, Filla M, Barrett-Wilt G . Comparative genomic and proteomic analysis of cytoskeletal changes in dexamethasone-treated trabecular meshwork cells. Mol Cell Proteomics. 2012; 12(1):194-206. PMC: 3536900. DOI: 10.1074/mcp.M112.019745. View

15.

Torriglia A, Valamanesh F, Behar-Cohen F . On the retinal toxicity of intraocular glucocorticoids. Biochem Pharmacol. 2010; 80(12):1878-86. DOI: 10.1016/j.bcp.2010.07.012. View

16.

Ramu J, Chatziralli I, Yang Y, Menon G, Bailey C, Eckstein M . Health-related quality of life, visual function and treatment satisfaction following intravitreal dexamethasone implant for diabetic macular edema. Patient Prefer Adherence. 2017; 11:579-586. PMC: 5364019. DOI: 10.2147/PPA.S132859. View

17.

Kiernan D, Mieler W . The use of intraocular corticosteroids. Expert Opin Pharmacother. 2009; 10(15):2511-25. DOI: 10.1517/14656560903160671. View

18.

Ramamoorthy S, Cidlowski J . Corticosteroids: Mechanisms of Action in Health and Disease. Rheum Dis Clin North Am. 2015; 42(1):15-31, vii. PMC: 4662771. DOI: 10.1016/j.rdc.2015.08.002. View

19.

Gu R, Lei B, Jiang C, Xu G . Glucocorticoid-Induced Leucine Zipper Suppresses ICAM-1 and MCP-1 Expression by Dephosphorylation of NF-κB p65 in Retinal Endothelial Cells. Invest Ophthalmol Vis Sci. 2017; 58(1):631-641. DOI: 10.1167/iovs.16-20933. View

20.

Ayroldi E, Cannarile L, Migliorati G, Nocentini G, Delfino D, Riccardi C . Mechanisms of the anti-inflammatory effects of glucocorticoids: genomic and nongenomic interference with MAPK signaling pathways. FASEB J. 2012; 26(12):4805-20. DOI: 10.1096/fj.12-216382. View